Live Breaking News & Updates on Franz werner haas

Stay informed with the latest breaking news from Franz werner haas on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Franz werner haas and stay connected to the pulse of your community

LimmaTech Biologics Reports Positive Interim Phase I/II Clinical Data on Tetravalent Shigella Bioconjugate Vaccine S4V

SCHLIEREN, Switzerland, February 22, 2024--LimmaTech Biologics AG announced positive interim data from its Phase I/II clinical trial evaluating Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis, an infectious disease caused by Shigella bacteria. Shigellosis is a serious infection and remains the second leading cause of fatal diarrheal disease, particularly in infants in low- and middle-income countries. In the nine-month-old target population, administration of S

Kenya , United-kingdom , Switzerland , Limmatech-biologics , Alexander-siebert , Patricia-martin , Franz-werner-haas , Network-meeting , Trophic-communications , Wellcome , Chief-operating-officer , Annual-network-meeting

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Australia , Australian , Franz-werner-haas , Paul-wolfrom , Alexander-siebert , Nicola-forrest , Limmatech-biologics , Steve-burnell , Stefan-klotter , Trophic-communications , Impact-fund , Novo-holdings

LimmaTech Biologics Raises Additional $3M in Series A

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland , Limmatech-biologics , Franz-werner-haas , Novo-holdings , Impact-fund , Adjuvant-capital ,

LimmaTech, AbVacc sign agreement for S. aureus vaccine candidate

LimmaTech, AbVacc entered into agreement, providing the former with exclusive rights for development of the latter's multivalent toxoid vaccine candidate

Franz-werner-haas , National-institutes-of-health , National-institute-of-allergy , National-institute , Infectious-diseases , National-institutes ,

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Germany , Sudan , Gretchen-schweitzer , Javad-aman , Franz-werner-haas , Limmatech-biologics , Michael-kowarik , National-institutes-of-health , Biomedical-advanced-research , Development-authority , Impact-fund

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

SCHLIEREN, Switzerland, October 09, 2023--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr

United-states , New-york , Switzerland , London , City-of , United-kingdom , Alexander-siebert , Kabeer-aziz , Zina-affas-besse , Limmatech-biologics , Franz-werner-haas , Camilla-petrycer-hansen

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , New-york , London , City-of , United-kingdom , Zina-affas-besse , Hooft-van-huijsduijnen , Camilla-petrycer-hansen , Alexander-siebert , Franz-werner-haas , Limmatech-bio , Limmatech-biologics

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidru

SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platfor...

United-states , New-york , London , City-of , United-kingdom , Zina-affas-besse , Camilla-petrycer-hansen , Kabeer-aziz , Limmatech-bio , Alexander-siebert , Hooft-van-huijsduijnen , Franz-werner-haas

LimmaTech Biologics Raises $37M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland , Limmatech-biologics , Kabeer-aziz , Camilla-petrycer-hansen , Zina-affas-besse , Franz-werner-haas , Novo-holdings , Impact-fund , Adjuvant-capital ,

CureVac N : Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) - Form 6-K -Today at 04:37 pm

CureVac N.V.

Interim Condensed Consolidated Statements of Operations and

Other Comprehensive Income

...

Russia , Ukraine , Amsterdam , Noord-holland , Netherlands , United-states , Switzerland , Belgium , Germany , German , Russian , Dutch